Tigecycline

Last Updated: 04/28/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 5843 publications

Phenotypic and genomic characterization of tigecycline-insensitive Klebsiella pneumoniae strains and validation of highly virulent MDR strains.

Phenotypic and genomic characterization of tigecycline-insensitive Klebsiella pneumoniae strains and validation of highly virulent MDR strains.

Journal: Microbiology spectrum
Published: April 08, 2026

Evaluation of the post-antibiotic effect against Mycobacterium abscessus by a bioluminescence method.

Evaluation of the post-antibiotic effect against Mycobacterium abscessus by a bioluminescence method.

Journal: Microbiology spectrum
Published: April 07, 2026

Antibiotic dose-response curves can measure antibiotic activity against Mycobacterium abscessus and Mycobacterium peregrinum.

Antibiotic dose-response curves can measure antibiotic activity against Mycobacterium abscessus and Mycobacterium peregrinum.

Journal: Antimicrobial agents and chemotherapy
Published: April 06, 2026

Mitochondrial protein translation is a heightened dependence and therapeutic vulnerability of chemo-refractory triple negative breast cancer.

Mitochondrial protein translation is a heightened dependence and therapeutic vulnerability of chemo-refractory triple negative breast cancer.

Journal: bioRxiv : the preprint server for biology
Published: April 03, 2026

Emergence of tmexCD1-toprJ1 in the clinical high-risk clone sequence type 147 among carbapenem-resistant Klebsiella pneumoniae isolates in China: A multicentre retrospective study.

Emergence of tmexCD1-toprJ1 in the clinical high-risk clone sequence type 147 among carbapenem-resistant Klebsiella pneumoniae isolates in China: A multicentre retrospective study.

Journal: Virulence
Published: April 02, 2026

Eravacycline for Mycobacterium abscessus infections: pharmacodynamic advantages of long-acting post-antibiotic effects and weekly dosing regimens.

Eravacycline for Mycobacterium abscessus infections: pharmacodynamic advantages of long-acting post-antibiotic effects and weekly dosing regimens.

Journal: Microbiology spectrum
Published: March 30, 2026

Whole-genome characteristics of isolates from recurrent Clostridioides difficile infections.

Whole-genome characteristics of isolates from recurrent Clostridioides difficile infections.

Journal: Microbiology spectrum
Published: March 27, 2026

Antimicrobial activity of sulbactam-durlobactam against Acinetobacter baumannii-calcoaceticus complex strains causing non-respiratory and non-bloodstream infections from the United States (2023-2025).

Antimicrobial activity of sulbactam-durlobactam against Acinetobacter baumannii-calcoaceticus complex strains causing non-respiratory and non-bloodstream infections from the United States (2023-2025).

Journal: Microbiology spectrum
Published: March 23, 2026

Erratum: Comparative in vitro Activity and Clinical Outcomes of Eravacycline, Tigecycline, and Omadacycline Against Carbapenem-Resistant Acinetobacter baumannii and Klebsiella pneumoniae [Corrigendum].

Erratum: Comparative in vitro Activity and Clinical Outcomes of Eravacycline, Tigecycline, and Omadacycline Against Carbapenem-Resistant Acinetobacter baumannii and Klebsiella pneumoniae [Corrigendum].

Journal: Infection and drug resistance
Published: March 19, 2026

Clinical practice guideline for the use of new-generation tetracycline-class antibiotics in pediatrics (2026 edition)

Clinical practice guideline for the use of new-generation tetracycline-class antibiotics in pediatrics (2026 edition)

Journal: Zhonghua yi xue za zhi
Published: March 19, 2026

Genomic and functional characterization of a blaNDM-1 and tmexCD2-toprJ2 co-producing Klebsiella quasipneumoniae (KL159/ST1929) reveals plasmid-mediated suppression of virulence.

Genomic and functional characterization of a blaNDM-1 and tmexCD2-toprJ2 co-producing Klebsiella quasipneumoniae (KL159/ST1929) reveals plasmid-mediated suppression of virulence.

Journal: Microbiology spectrum
Published: March 17, 2026

Trends of Carbapenem-Resistant Gram-negative Bacteria in China: A Surveillance Study Between 2015 and 2024.

Trends of Carbapenem-Resistant Gram-negative Bacteria in China: A Surveillance Study Between 2015 and 2024.

Journal: The Journal of infectious diseases
Published: March 13, 2026
Showing 1-12 of 5,843

Last Updated: 04/28/2026